Mathios, Dimitrios
Johansen, Jakob Sidenius http://orcid.org/0000-0002-1470-1516
Cristiano, Stephen
Medina, Jamie E.
Phallen, Jillian http://orcid.org/0000-0002-5492-9013
Larsen, Klaus R.
Bruhm, Daniel C.
Niknafs, Noushin
Ferreira, Leonardo
Adleff, Vilmos
Chiao, Jia Yuee
Leal, Alessandro http://orcid.org/0000-0001-7967-3213
Noe, Michael
White, James R.
Arun, Adith S.
Hruban, Carolyn
Annapragada, Akshaya V. http://orcid.org/0000-0002-9097-6511
Jensen, Sarah Østrup http://orcid.org/0000-0001-6044-3362
Ørntoft, Mai-Britt Worm
Madsen, Anders Husted
Carvalho, Beatriz http://orcid.org/0000-0003-4903-399X
de Wit, Meike
Carey, Jacob
Dracopoli, Nicholas C.
Maddala, Tara
Fang, Kenneth C.
Hartman, Anne-Renee
Forde, Patrick M.
Anagnostou, Valsamo http://orcid.org/0000-0001-9480-3047
Brahmer, Julie R.
Fijneman, Remond J. A. http://orcid.org/0000-0003-2076-5521
Nielsen, Hans Jørgen
Meijer, Gerrit A.
Andersen, Claus Lindbjerg http://orcid.org/0000-0002-7406-2103
Mellemgaard, Anders
Bojesen, Stig E. http://orcid.org/0000-0002-4061-4133
Scharpf, Robert B. http://orcid.org/0000-0003-4702-2656
Velculescu, Victor E. http://orcid.org/0000-0003-1195-438X
Funding for this research was provided by:
Dr. Miriam and Sheldon G. Adelson Medical Research Foundation
SU2C in-Time Lung Cancer Interception Dream Team Grant, Stand Up to Cancer-Dutch Cancer Society International Translational Cancer Research Dream Team Grant
Article History
Received: 27 April 2021
Accepted: 12 July 2021
First Online: 20 August 2021
Competing interests
: D.M., S.C., J.P., A.L., V.A., R.B.S., and V.E.V. are inventors on patent applications submitted by Johns Hopkins University related to cell-free DNA for cancer detection. S.C., J.P., A.L., V.A., and R.B.S. are founders of Delfi Diagnostics, and V.A. and R.B.S are consultants for this organization. V.E.V. is a founder of Delfi Diagnostics and Personal Genome Diagnostics, serves on the Board of Directors and as a consultant for both organizations, and owns Delfi Diagnostics and Personal Genome Diagnostics stock, which are subject to certain restrictions under university policy. In addition, Johns Hopkins University owns equity in Delfi Diagnostics and Personal Genome Diagnostics. The technology used in the study described in this publication has been licensed to one or more entities. Under the terms of these license agreements, the University and inventors are entitled to fees and royalty distributions. V.E.V. is an advisor to Bristol-Myers Squibb, Genentech, and Takeda Pharmaceuticals. Within the last five years, V.E.V. has been an advisor to Merck and Ignyta. These arrangements have been reviewed and approved by the Johns Hopkins University in accordance with its conflict of interest policies.